Figure 4.
Involvement of DNA damage signaling in the induction of mRNA expression of CXCL9/10/11 by T-DXd in HER2-positive GC cells. (A) Comparison of mRNA expression (z-score) of CXCL9, CXCL10, and CXCL11 between ERBB2 amplified GC tissues (Amp) (n = 55) and ERBB2 non-amplified GC tissues (Diploid) (n = 238) from TCGA dataset. (B) Correlation among mRNA expression (z-score) of CXCL9, CXCL10, CXCL11, CHEK1, CHEK2, and TP53 in samples from 412 patients with GC from TCGA dataset. (C) qPCR analysis of CXCL9, CXCL10, and CXCL11 in NCI-N87 cells treated with 1 μg/ml T-DXd in the absence or presence of 10 μM KU-55933 (KU), 10 μM VE-821 (VE), or 100 nM UCN-01 (UCN) for 72 h (n = 3). Values are shown as means ± SEM. *P < 0.05, **P < 0.01, ****P < 0.0001.